These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 4151750)
1. Why do schizophrenic patients refuse to take their drugs? Van Putten T Arch Gen Psychiatry; 1974 Jul; 31(1):67-72. PubMed ID: 4151750 [No Abstract] [Full Text] [Related]
2. Sex differences in long-term adverse effects of phenothiazines. Lehmann HE; Ban TA Adv Biochem Psychopharmacol; 1974; 9(0):249-54. PubMed ID: 4151763 [No Abstract] [Full Text] [Related]
4. Neuroleptics and neurologic reactions. Marcotte DB South Med J; 1973 Mar; 66(3):321-4. PubMed ID: 4144147 [No Abstract] [Full Text] [Related]
5. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs]. Vatsek Ia Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940 [No Abstract] [Full Text] [Related]
6. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia. Villeneuve A; Pires A; Jus A; Lachance R; Drolet A Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626 [No Abstract] [Full Text] [Related]
7. The management of schizophrenia. Bennett DH Br J Psychiatry; 1975; Spec No 9():48-54. PubMed ID: 241452 [No Abstract] [Full Text] [Related]
8. [Pilot study on oxaflumazine, a new piperazinated phenothiazine]. Villeneuve A; Dogan K; Lachance R; Drolet A Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378 [No Abstract] [Full Text] [Related]
9. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients. Elizur A; Segal S; Yeret A; Ben-David M Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877 [No Abstract] [Full Text] [Related]
10. Persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. Hershon HI; Kennedy PF; McGuire RJ Br J Psychiatry; 1972 Jan; 120(554):41-50. PubMed ID: 4557435 [No Abstract] [Full Text] [Related]
12. [Additional possibilities for correction of movement disorders induced by neuroleptics in patients with schizophrenia]. Semenikhin DG; Kuchaeva AV; Karpov AM; Mikhaĭlova EB; Murav'eva AV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):78-80. PubMed ID: 24429952 [No Abstract] [Full Text] [Related]
13. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. Casey DE Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821 [No Abstract] [Full Text] [Related]
14. Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia. Bullock RJ Med J Aust; 1972 Aug; 2(6):314-6. PubMed ID: 4404280 [No Abstract] [Full Text] [Related]
15. [Difficulties in neuroleptic treatment of schizophrenic patients]. Woggon B Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):55-9. PubMed ID: 2579426 [TBL] [Abstract][Full Text] [Related]
16. All antipsychotics are equal, but some are more equal than others. Volavka J; Citrome L J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959 [No Abstract] [Full Text] [Related]
17. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important. Anderson I BMJ; 2001 Apr; 322(7291):926; author reply 927-8. PubMed ID: 11302919 [No Abstract] [Full Text] [Related]
18. Disturbed voluntary motor activity in schizophrenic disorder. Manschreck TC; Maher BA; Rucklos ME; Vereen DR Psychol Med; 1982 Feb; 12(1):73-84. PubMed ID: 6123128 [No Abstract] [Full Text] [Related]